MEI Pharma Inc (MEIP)
3.235
-0.02
(-0.77%)
USD |
NASDAQ |
Apr 25, 13:34
MEI Pharma Cash from Operations (TTM): -52.98M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -52.98M |
September 30, 2023 | -56.19M |
June 30, 2023 | -52.48M |
March 31, 2023 | -56.69M |
December 31, 2022 | -61.51M |
September 30, 2022 | -55.81M |
June 30, 2022 | -48.75M |
March 31, 2022 | -44.50M |
December 31, 2021 | -43.19M |
September 30, 2021 | -30.57M |
June 30, 2021 | -31.96M |
March 31, 2021 | 48.40M |
December 31, 2020 | 53.76M |
September 30, 2020 | 39.22M |
June 30, 2020 | 34.26M |
March 31, 2020 | -42.92M |
December 31, 2019 | -43.96M |
September 30, 2019 | -30.68M |
June 30, 2019 | -29.42M |
March 31, 2019 | -24.84M |
December 31, 2018 | -19.74M |
September 30, 2018 | -27.29M |
June 30, 2018 | -21.04M |
March 31, 2018 | -20.70M |
December 31, 2017 | -12.85M |
Date | Value |
---|---|
September 30, 2017 | -11.85M |
June 30, 2017 | 3.486M |
March 31, 2017 | 3.149M |
December 31, 2016 | -2.842M |
September 30, 2016 | -3.323M |
June 30, 2016 | -17.86M |
March 31, 2016 | -21.12M |
December 31, 2015 | -24.88M |
September 30, 2015 | -27.10M |
June 30, 2015 | -28.07M |
March 31, 2015 | -27.18M |
December 31, 2014 | -24.10M |
September 30, 2014 | -22.12M |
June 30, 2014 | -19.45M |
March 31, 2014 | -16.37M |
December 31, 2013 | -13.93M |
September 30, 2013 | -11.62M |
June 30, 2013 | -10.04M |
March 31, 2013 | -8.582M |
December 31, 2012 | -8.224M |
September 30, 2012 | -7.838M |
June 30, 2012 | -7.081M |
March 31, 2012 | -7.411M |
December 31, 2011 | -6.849M |
September 30, 2011 | -6.727M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-61.51M
Minimum
Dec 2022
53.76M
Maximum
Dec 2020
-26.63M
Average
-43.19M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Merck & Co Inc | 13.01B |
United Therapeutics Corp | 978.00M |
Macrogenics Inc | -78.20M |
Voyager Therapeutics Inc | 77.92M |
Moderna Inc | -3.118B |